Evidence map›Paper›PMID 41593767›Full record

ReviewVirology journal2026

CD163 at the crossroads: a viral-exploited immunomodulator.

Jiayong Tan, Jie Cheng, Xiaohui Yang, Jian Zhang, Huaqiang Yang

Abstract readReview
In one paragraph

Review in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiayong TanState Key Laboratory of Swine and Poultry Breeding Industry, National Engineering Research Center for Breeding Swine Industry, College of Animal Science, South China Agricultural University, Guangzhou, 510642, China.
Jie ChengState Key Laboratory of Swine and Poultry Breeding Industry, National Engineering Research Center for Breeding Swine Industry, College of Animal Science, South China Agricultural University, Guangzhou, 510642, China.
Xiaohui YangState Key Laboratory of Swine and Poultry Breeding Industry, National Engineering Research Center for Breeding Swine Industry, College of Animal Science, South China Agricultural University, Guangzhou, 510642, China.
Jian ZhangState Key Laboratory of Swine and Poultry Breeding Industry, National Engineering Research Center for Breeding Swine Industry, College of Animal Science, South China Agricultural University, Guangzhou, 510642, China.
Huaqiang YangState Key Laboratory of Swine and Poultry Breeding Industry, National Engineering Research Center for Breeding Swine Industry, College of Animal Science, South China Agricultural University, Guangzhou, 510642, China. yangh@scau.edu.cn.

Funding

Department of Agriculture and Rural Affairs of Guangdong Province 2024-XPY-00-015Ministry of Agriculture and Rural Affairs of the People's Republic of China 2023ZD0404303
6 · The paper itself

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) is a major pathogen in pigs and poses a significant economic threat to the pig industry. CD163 acts as a key cellular receptor for PRRSV infection, mediating viral entry into host cells. Beyond functioning as a viral entry factor, CD163 plays multifaceted roles in PRRSV infection by linking viral pathogenesis with host immune regulation. This review summarizes current understanding of CD163's structure, physiological functions, mechanisms in PRRSV entry, and immunomodulatory roles during infection. We explore how CD163 expression and ectodomain shedding influence macrophage polarization and cytokine dynamics, thereby shaping viral persistence and tissue injury. Key evidence indicates that PRRSV harnesses anti-inflammatory signaling to sustain CD163 expression and promote entry, whereas pro-inflammatory stimuli downregulate CD163 and restrict replication. Shed soluble CD163 (sCD163) exhibits dual functions: it can act as a decoy receptor to mitigate viral spread, yet may also exacerbate inflammatory pathology. We also review recent advances in CD163-targeted interventions, including gene-edited pigs resistant to PRRSV, neutralizing antibodies, and small-molecule inhibitors that disrupt CD163-virus interactions. Critical analysis supports that targeted deletion or modification of CD163 confers viral resistance without impairing its essential physiological functions. In summary, CD163 functions not only as a gateway for PRRSV entry but also as an immunomodulator influencing disease outcomes. Elucidating this duality provides new perspectives for developing control strategies that combine effective viral blockade with the maintenance of immune homeostasis.

Indexed as

Antigens, CDAntigens, Differentiation, MyelomonocyticImmunologic FactorsPorcine Reproductive and Respiratory SyndromePorcine respiratory and reproductive syndrome virusReceptors, Cell SurfaceReceptors, VirusAnimalsCD163 AntigenHost-Pathogen InteractionsImmunomodulationMacrophagesSwineVirus InternalizationAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenImmunologic FactorsReceptors, Cell SurfaceReceptors, VirusAnti-viral breedingCD163Gene editingHost-viral interactionImmunomodulationInflammationMacrophagesPRRSV

Identifiers

PMID41593767
PMCPMC12918507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.